𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human phenolsulfotransferases: chiral substrates and expression in Hep G2 cells

✍ Scribed by Thomas Walle; U.Kristina Walle; Jill A. Shwed; Kelly R. Thornburg; Chad E. Mathis; Gene R. Pesola

Book ID
113137785
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
482 KB
Volume
92
Category
Article
ISSN
0009-2797

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Methotrexate induction of human sulfotra
Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells
✍ Xinrong Chen; Sharon M. Baker; Guangping Chen πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 359 KB

Methotrexate (MTX) was the first antifolate drug developed for the treatment of cancer. It is also effective in treating inflammatory and autoimmune diseases. Sulfotransferases are phase II drug-metabolizing enzymes and their induction by hormones and endogenous molecules is relatively well known, a

Human herpesvirus 6 induces IL-8 gene ex
Human herpesvirus 6 induces IL-8 gene expression in human hepatoma cell line, Hep G2
✍ Inagi, Reiko; Guntapong, Ratigorn; Nakao, Masayuki; Ishino, Yoshizumi; Kawanishi πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 722 KB

The infectivity of human herpesvirus 6 (HHV-6) in a human hepatoma cell line, Hep G2 cells, and the effect of HHV-6 on production of inflammatory cytokines in these cells were examined to analyze pathogenesis of HHV-6 in the liver. We demonstrated that Hep G2 cells were susceptible to infection with

3,5,3β€²triiodo-L-thyronine induces SREBP-
3,5,3β€²triiodo-L-thyronine induces SREBP-1 expression by non-genomic actions in human HEP G2 cells
✍ Gabriele V. Gnoni; Alessio Rochira; Antonella Leone; Fabrizio Damiano; Santo Mar πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

Liver is an important target for thyroid hormone actions. T 3 exerts its effects by two mechanisms: (i) Genomic actions consisting of T 3 link to nuclear receptors that bind responsive elements in the promoter of target genes, (ii) non-genomic actions including integrin avb3 receptor-mediated MAPK/E